Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of an Educational Program in the Prevention of the Driving Risks in Patients With Neurocognitive Disorders : ACCOMPAGNE

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* aged between 50 and 95 years-old~* hold a driving license,~* drive at least twice a week,~* to have given free and informed consent,~* present a diagnosis of major or minor CNS according to DSM V, whose clinically probable or definite etiology is Alzheimer's or related or vascular disease,~* have a result in the Mini Mental State Examination (MMSE) greater than 18,~* have the ability to speak orally enough or write enough to perform clinical evaluations and workshops, be accompanied by a family member present at least 4 hours a week.~Criteria for inclusion of carers:~* to be a caregiver helping the patient for activities of daily living,~* to have given their free and informed consent,~* have the ability to speak orally and write enough to perform clinical assessments.~Exclusion Criteria:~* have a major psychiatric history, history of alcoholism, anti-depressant~* have sensory problems preventing participation in workshops,~* be affected by any debilitating pathology compromising the health of the patient in the short and medium term,~* be unable to express consent. Criteria for non-inclusion of caregivers: have sensory disturbances preventing participation in workshops.~Recruited patients and caregivers should have been informed and signed a consent.

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 95 Years
- Healthy Volunteers: f

Study Arms:
- educational intervention (Type: EXPERIMENTAL): Patients and caregivers included in the ACCOMPAGNE Education Program group will benefit from seven group workshops spread over three half-days (once a week over 3 consecutive weeks), animated in pairs, each lasting approximately one and a half hours. and using educational pedagogical methods.
- Control group (Type: ACTIVE_COMPARATOR): Patients and caregivers included in the Control group will receive the usual recommendations for driving, issued by their referring doctor in memory consultation during the diagnostic announcement process or during the follow-up of their illness.

Based on this trial design, predict the completion outcome and termination type (if applicable).